Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Nov 14, 2013 · 10-Q · 45 days after period end · 0001213900-13-006378
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.42M | -$3.01M | -$3.51K | -$9.68K |
| EPS Diluted | -$0.06 | -$3.76 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 14, 2013 · 45 d after period end
